SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-113203
Filing Date
2022-04-21
Accepted
2022-04-21 17:20:01
Documents
13
Period of Report
2022-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d304763d8k.htm   iXBRL 8-K 29557
2 EX-10.1 d304763dex101.htm EX-10.1 82668
  Complete submission text file 0001193125-22-113203.txt   260759

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fixx-20220419.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20220419_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20220419_pre.xml EX-101.PRE 11280
7 EXTRACTED XBRL INSTANCE DOCUMENT d304763d8k_htm.xml XML 3344
Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 22842380
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences